Apolipoprotein A-IV inhibits experimental colitis

Journal of Clinical Investigation

Volumn 114, Issue 2, 2004, Pages 260-269

  Vowinkel, Thorsten ^a,b   Mori, Mikiji ^a   Krieglstein, Christian F ^b   Russell, Janice ^a   Saijo, Fumito ^c   Bharwani, Sulaiman ^c   Turnage, Richard H ^c   Davidson, W Sean ^d   Tso, Patrick ^d   Granger, D Neil ^a   Kalogeris, Theodore J ^a,c  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Louisiana State University School of Medicine Shreveport   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; DEXTRAN SULFATE; MYELOPEROXIDASE; PADGEM PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; COLON; COLON MUCOSA; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE ADHERENCE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; THROMBOCYTE ADHESION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEINS A; COLITIS; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; INDICATORS AND REAGENTS; INFLAMMATION; INTESTINAL MUCOSA; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P-SELECTIN; PLATELET ADHESIVENESS; RECOMBINANT PROTEINS;

EID: 4043165724     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200421233     Document Type: Article

References (58)

1. Swaney, J.B., Braithewaite, F., and Eden, H.A. 1977. Characterization of the apolipoproteins of rat plasma lipoproteins. Biochemistry. 16:271-278.
2. Apfelbaum, T.F., Davidson, N.O., and Gickman, R.M. 1987. Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am. J. Physiol. 252:G662-G666.
3. Hayashi, H., et al. 1990. Transport of lipid and apoliproteins A-I and A-IV in intestinal lymph of the rat. J. Lipid Res. 31:1613-1625.
4. Kalogeris, T.J., Fukagawa, K., and Tso, P. 1994. Synthesis and lymphatic transport of intestinal apolipoprotein A-IV in response to graded doses of triglyceride. J. Lipid Res. 35:1141-1151.
5. Ghiselli, G., Krishna, S., Beigle, Y., and Gotto, A.M. 1986. Plasma metabolism of apolipoprotein A-IV in humans. J. Lipid Res. 27:813-827.
6. Lefevre, M., and Roheim, P.S. 1984. Metabolism of apolipoprotein A-IV. J. Lipid Res. 25:1603-1610.
7. Goldberg, I.J., Scheraldi, C.A., Yacoub, L.K., Saxena, U., and Bisgaier, C.L. 1990. Lipoprotein C-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J. Biol. Chem. 265:4266-4272.
8. Bisgaier, C.L., et al. 1987. Effect of lecithin: cholesterol acyl transferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma. J. Lipid Res. 28:693-703.
9. Fielding, C.J., Shore, V.G., and Fielding, P.E. 1972. A protein cofactor of lecithin: cholesterol acyltransferase. Biochem. Biophys. Res. Commun. 46:1493-1498.
10. Dvorin, E., Gorder, N.L., Benson, D.M., and Gotto, A.M. 1988. Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J. Biol. Chem. 261:15714-15718.
11. Stein, O., Stein, Y., Lefevre, M., and Roheim, P. 1986. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim. Biophys. Acta. 878:7-13.
12. Fujimoto, K., Cardelli, J.A., and Tso, P. 1992. Increased apolipoprotein A-IV in rat mesenteric lymph acts as a physiological signal for satiation. Am. J. Physiol. 262:G1002-G1008.
13. Fujimoto, K., Fukagawa, K., Sakata, T., and Tso, P. 1993. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J. Clin. Invest. 91:1830-1833.
14. Okumura, T., Fukagawa, K., Tso, P., Taylor, I.L., and Pappas, T.N. 1994. Intracisternal injection of apolipoprotein A-IV inhibits gastric secretion in pylorus-ligated rats. Gastroenterology. 107:1861-1864.
15. Duverger, N., et al. 1996. Protection against atherosclerosis in mice mediated by human apolipoprotein A-IV. Science. 273:966-968.
16. Cohen, R.D., et al. 1997. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J. Clin. Invest. 99:1906-1916.
17. Fournier, N., et al. 2000. Human apo A-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler. Thromb. Vasc. Biol. 20:1283-1292.
18. Ostos, M.A., et al. 2001. Antioxidative and anriatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:1023-1028.
19. Qin, X., Swertfeger, D.K., Sheng, S., Hui, D.Y., and Tso, P. 1998. Apolipoprotein A-IV: a potent endogenous inhibitor of lipid oxidation. Am. J. Physiol. 274:H1836-H1840.
20. Ferretti, G., Baccheti, T., Bicchiega, V., and Curatola, G. 2002. Effect of human apo A-IV against lipid peroxidation of very low density lipoproteins. Chem. Phys. Lipids. 114:45-54.
21. Remaley, A.T., et al. 2001. Apolipoprotein specificity for lipid efflux by the human ABCA1 transporter. Biochem. Biophys. Res. Commun. 280:818-823.
22. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801-809.
23. Cooper, D., Stokes, K.Y., Tailor, A., and Granger, D.N. 2002. Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation. Cardiovasc. Toxicol. 2:165-180.
24. Elson, C.O., Sartor, R.B., Tennyson, G.S., and Riddel, R.H. 1995. Experimental models of inflammatory bowel disease. Gastroenterology. 109:1344-1367.
25. Cooper, H.S., Mutthy, S.N.S., Shah, R.S., and Sedergran, D.J. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69:238-249.
26. Okayasu, I., et al. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 98:694-702.
27. Krieglstein, C.F., et al. 2001. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J. Exp. Med. 9:1207-1218.
28. 1 regulates intestinal inflammation in experimental colitis. J. Clin. Invest. 110:1773-1782. doi:10.1172/JCI200215256.
29. Vowinkel, T., Kalogeris, T.J., Mori, M., Krieglstein, C.F., and Granger, D.N. 2004. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig. Dis. Sci. 49:556-564.
30. Dieleman, L.A., et al. 1998. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 114:385-391.
31. Kruidenier, L., et al. 2003. Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Radic. Biol. Med. 34:753-765.
32. Gironella, M., et al. 2002. The role of P-selectin in experimental colitis as determined by antibody blockade and genetically deficient mice. J. Leukoc. Biol. 72:56-64.
33. Ganesan, R., and Summers, C. 1989. Glucocorticoids potentiate the dipsogenic action of angiotensin II. Brain Res. 499:121-130.
34. Perez Guaita, M.F., and Chiaraviglio, E. 1980. Effect of prostaglandin E1 and its biosynthesis inhibitor indomethacin on drinking in the rat. Pharmacol. Biochem. Behav. 13:787-792.
35. Siegmund, B., Lehr, H.A., and Fantucci, G. 2002. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology. 122:2011-2025.
36. Domek, M.J., et al. 1995. Anti-neutrophil serum attenuates dextran sulfate sodium-induced colonic damage in the rat. Scand. J. Gastroenterol. 30:1089-1094.
37. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301-314.
38. Panés, J., and Granger, D.N. 1998. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology. 114:1066-1090.
39. Schuermann, G.M., et al. 1995. Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut. 36:411-418.
40. Wan, X.W., et al. 2002. Leukocyte rolling is exclusively mediated by P-selectin in colonic venules. Br. J. Pbarmacol. 135:1749-1756.
41. Collins, C.E., Rampton, D.S., Rogers, J., and Williams, N.S. 1997. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 9:1213-1217.
42. Collins, C.E., and Rampton, D.S. 1995. Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut. 36:5-8.
43. Collins, C.E., Cahill, M.R., Newland, A.C., and Rampton, D.S. 1994. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology. 106:840-845.
44. Talbot, R.W., Heppell, J., Dozois, R.R., and Beart, R.W., Jr. 1986. Vascular complications of inflammatory bowel disease. Mayo Clin. Proc. 61:140-145.
45. Danese, S., et al. 2003. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease. Gastroenterology. 124:1249-1264.
46. Nofer, J.R., et al. 2002. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 161:1-16.
47. Burger, D., and Dayer, J.M. 2002. High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation. Autoimmun. Rev. 1:111-117.
48. Cockerill, G.W., et al. 2001. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation. 103:108-112.
49. Saijo, F., et al. 2003. Apolipoprotein A-IV protects vascular endorhelial cells from oxidant-induced barrier dysfunction [abtsract]. FASEB J. 17:A885.
50. Spaulding, H.L., Aw, T.Y., and Kalogeris, T.J. 2004. Apolipoprotein A-IV prevents oxidant-induced, redox-dependent apoptosis [abstract]. FASEB J. 18:A1030.
51. Weinstock, P.H., et al. 1997. Decreased HDL cholesterol levels but normal absorption, growth and feeding behavior in apolipoprotein A-IV knockout mice. J. Lipid Res. 38:1782-1794.
52. Duverger, N., et al. 1991. Functional characterization of human recombinant apolipoprotein A-IV produced in Escherichia coli. Eur. J. Biochem. 201:373-383.
53. Panagotopulos, S.E., Witting, S.R., Horace, E.M., Maiorano, N.J., and Davidson, W.S. 2002. Bacterial expression and characterization of mature apolipoprotein A-I. Protein Expr. Purif. 25:353-361.
54. Ebaugh, F.G. 1959. Quantitative measurement of gastrointestinal blood loss. J. Lab. Clin. Med. 53:777-788.
55. Arndt, H., Kubes, P., Grisham, M.B., Gonzalez, E., and Granger, D.N. 1992. Granulocyte turnover in the feline intestine. Inflammation. 16:549-559.
56. Ktawisz, J.E., Shaton, P., and Stenson, W.F. 1984. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 87:1344-1350.
57. Cooper, D., Chitman, K.D., Williams, M.C., and Granger, D.N. 2003. Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G1027-G1033.
58. Eppiheimer, M.J., Wolitzky, B., Anderson, D.C., Labow, M.A., and Granger, D.N. 1996. Heterogeneity of E- and P-selectins in vivo. Circ. Res. 79:560-569.